Trial Outcomes & Findings for Trial of Scrambler Therapy or Sham Treatment for Low Back Pain (NCT NCT01896687)

NCT ID: NCT01896687

Last Updated: 2017-06-14

Results Overview

Low back pain will be measured by the Brief Pain Inventory (BPI). The BPI assesses the severity of pain, location of pain, pain medications, amount of pain relief in the past 24 hours and the past week, and the impact of pain on daily functions. For this study, the worst pain score will be used in the analysis. The worst pain score is rated from "0" meaning no pain to "10" meaning pain as bad as you can imagine.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

30 participants

Primary outcome timeframe

baseline to 3 weeks post-treatment

Results posted on

2017-06-14

Participant Flow

Participant milestones

Participant milestones
Measure
Scrambler Therapy
Scrambler therapy applied to region of low back pain for 30 minutes x 10 days Scrambler: Electrotherapy
Sham Scrambler Treatment
Sham treatment applied to region above low back pain at nontherapeutic dose for 30 minutes x 10 days Scrambler: Electrotherapy
Overall Study
STARTED
15
15
Overall Study
COMPLETED
15
15
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Trial of Scrambler Therapy or Sham Treatment for Low Back Pain

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Scrambler Therapy
n=15 Participants
Scrambler therapy applied to region of low back pain for 30 minutes x 10 days Scrambler: Electrotherapy
Sham Scrambler Treatment
n=15 Participants
Sham treatment applied to region above low back pain at nontherapeutic dose for 30 minutes x 10 days Scrambler: Electrotherapy
Total
n=30 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
15 Participants
n=5 Participants
15 Participants
n=7 Participants
30 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Sex: Female, Male
Female
8 Participants
n=5 Participants
11 Participants
n=7 Participants
19 Participants
n=5 Participants
Sex: Female, Male
Male
7 Participants
n=5 Participants
4 Participants
n=7 Participants
11 Participants
n=5 Participants
Region of Enrollment
United States
15 participants
n=5 Participants
15 participants
n=7 Participants
30 participants
n=5 Participants

PRIMARY outcome

Timeframe: baseline to 3 weeks post-treatment

Low back pain will be measured by the Brief Pain Inventory (BPI). The BPI assesses the severity of pain, location of pain, pain medications, amount of pain relief in the past 24 hours and the past week, and the impact of pain on daily functions. For this study, the worst pain score will be used in the analysis. The worst pain score is rated from "0" meaning no pain to "10" meaning pain as bad as you can imagine.

Outcome measures

Outcome measures
Measure
Scrambler Therapy
n=15 Participants
Scrambler therapy applied to region of low back pain for 30 minutes x 10 days Scrambler: Electrotherapy
Sham Scrambler Treatment
n=15 Participants
Sham treatment applied to region above low back pain at nontherapeutic dose for 30 minutes x 10 days Scrambler: Electrotherapy
Worst Low Back Pain Score
Baseline Mean Worse Pain Score
5.4 units on a scale
Standard Deviation 2.1
4.9 units on a scale
Standard Deviation 1.5
Worst Low Back Pain Score
3-week post-treatment mean worst pain score
3.2 units on a scale
Standard Deviation 1.2
5.8 units on a scale
Standard Deviation 1.7

Adverse Events

Scrambler Therapy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Sham Scrambler Treatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Angela Starkweather

Virginia Commonwealth University

Phone: 8048283986

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place